Prominent Sponsors 33
Top Companies Participating in Acute Myelocytic Leukemia ( AML , Acute Myeloblastic Leukemia ) Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Acute Myelocytic Leukemia ( AML , Acute Myeloblastic Leukemia ) 39
Feb 23 , 2017 : Cyclacel Announces Top-Line Results From Pivotal Phase 3 SEAMLESS Study in Elderly Patients With Acute Myeloid Leukemia 39
Feb 23 , 2017 : Children ’ s National Health System Experts Present Data on Novel Approach to Cell Therapy for Cancer Patients 40
Feb 17 , 2017 : Immune Pharmaceuticals Announces the launch of REMAIN , an international Overall Survival study with Ceplene and low dose Proleukin in REmission MAINtenance in Acute Myeloid Leukemia 40
Feb 13 , 2017 : Actinium Pharmaceuticals Presents Data On Actimab-A At BIO CEO & Investor Conference 41
Feb 06 , 2017 : FDA Grants Cellectis IND Approval to Proceed with the Clinical Development of UCART123 , the First Gene Edited Off-the-Shelf CAR T-Cell Product Candidate developed in the U . S . 41
Feb 06 , 2017 : INNATE PHARMA announces top-line results from EffiKIR trial evaluating the efficacy of lirilumab 41
Feb 02 , 2017 : Trillium Therapeutics Provides Update On TTI-622 42
Jan 11 , 2017 : Regenacy Pharma ' s HDAC1 Inhibitor ACY-957 Demonstrates Potent Anti-Leukemic Activities 42
Jan 11 , 2017 : Regenacy Pharma ' s HDAC2 Inhibitor ACY-1035 Demonstrates Potent Anti-Leukemic Activities 43
Jan 09 , 2017 : Syros Pharma Outlines 2017 Strategic Goals , Provides Update On SY-1425 43 Jan 05 , 2017 : Mirati Therapeutics Provides Update On Cancer Pre-Clinical Program 44
Jan 03 , 2017 : Cellectis Submits IND Application for UCART123 , an Allogeneic Gene Edited CAR T- Cell Product Candidate , in AML and BPDCN 44
Dec 28 , 2016 : argenx announces publication of seminal data supporting the therapeutic potential of ARGX-110 for acute myeloid leukemia in the Journal of Experimental Medicine 45
Dec 27 , 2016 : Seattle Genetics Announces Clinical Hold on Several Phase 1 Trials of Vadastuximab Talirine ( SGN-CD33A ) 45